American Research & Management Company’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $11.8M | Sell |
72,259
-81
| -0.1% | -$13.7K | 3.26% | 5 |
|
|
2022
Q2 | $12.8M | Buy |
72,340
+366
| +0.5% | +$65.2K | 3.3% | 4 |
|
|
2022
Q1 | $12.8M | Sell |
71,974
-272
| -0.4% | -$46.3K | 2.81% | 7 |
|
|
2021
Q4 | $12.4M | Sell |
72,246
-209
| -0.3% | -$34.2K | 2.67% | 10 |
|
|
2021
Q3 | $11.7M | Sell |
72,455
-516
| -0.7% | -$88K | 2.7% | 9 |
|
|
2021
Q2 | $12M | Sell |
72,971
-21
| -0% | -$3.48K | 2.74% | 10 |
|
|
2021
Q1 | $12M | Sell |
72,992
-2,324
| -3% | -$376K | 2.89% | 6 |
|
|
2020
Q4 | $11.9M | Buy |
75,316
+1,457
| +2% | +$215K | 3.08% | 6 |
|
|
2020
Q3 | $11M | Buy |
73,859
+2,443
| +3% | +$361K | 3.21% | 7 |
|
|
2020
Q2 | $10M | Sell |
71,416
-453
| -0.6% | -$66K | 3.05% | 8 |
|
|
2020
Q1 | $9.42M | Sell |
71,869
-3,309
| -4% | -$469K | 3.58% | 3 |
|
|
2019
Q4 | $11M | Sell |
75,178
-1,375
| -2% | -$187K | 3.25% | 5 |
|
|
2019
Q3 | $9.9M | Buy |
76,553
+905
| +1% | +$119K | 2.98% | 6 |
|
|
2019
Q2 | $10.5M | Sell |
75,648
-688
| -0.9% | -$95.2K | 3.15% | 6 |
|
|
2019
Q1 | $10.7M | Buy |
76,336
+975
| +1% | +$131K | 3.04% | 6 |
|
|
2018
Q4 | $9.72M | Sell |
75,361
-1,815
| -2% | -$253K | 3.28% | 5 |
|
|
2018
Q3 | $10.7M | Sell |
77,176
-675
| -0.9% | -$89.7K | 3.16% | 6 |
|
|
2018
Q2 | $9.45M | Buy |
77,851
+1,025
| +1% | +$128K | 3.28% | 5 |
|
|
2018
Q1 | $9.85M | Sell |
76,826
-2,077
| -3% | -$281K | 3.23% | 4 |
|
|
2017
Q4 | $11M | Sell |
78,903
-925
| -1% | -$129K | 3.4% | 4 |
|
|
2017
Q3 | $10.4M | Sell |
79,828
-1,300
| -2% | -$172K | 3.36% | 4 |
|
|
2017
Q2 | $10.7M | Sell |
81,128
-375
| -0.5% | -$47.8K | 3.53% | 3 |
|
|
2017
Q1 | $10.2M | Sell |
81,503
-2,704
| -3% | -$323K | 3.61% | 4 |
|
|
2016
Q4 | $9.7M | Sell |
84,207
-2,036
| -2% | -$235K | 3.32% | 5 |
|
|
2016
Q3 | $10.2M | Sell |
86,243
-935
| -1% | -$113K | 3.71% | 3 |
|
|
2016
Q2 | $10.6M | Sell |
87,178
-2,689
| -3% | -$306K | 4.06% | 4 |
|
|
2016
Q1 | $9.72M | Sell |
89,867
-885
| -1% | -$91.6K | 4.08% | 3 |
|
|
2015
Q4 | $9.32M | Sell |
90,752
-1,508
| -2% | -$152K | 3.98% | 1 |
|
|
2015
Q3 | $8.61M | Sell |
92,260
-900
| -1% | -$87.1K | 3.76% | 3 |
|
|
2015
Q2 | $9.08M | Sell |
93,160
-1,163
| -1% | -$116K | 3.68% | 4 |
|
|
2015
Q1 | $9.49M | Sell |
94,323
-3,588
| -4% | -$365K | 3.86% | 3 |
|
|
2014
Q4 | $10.2M | Sell |
97,911
-530
| -0.5% | -$55.9K | 3.78% | 4 |
|
|
2014
Q3 | $10.5M | Sell |
98,441
-1,593
| -2% | -$165K | 3.78% | 4 |
|
|
2014
Q2 | $10.5M | Sell |
100,034
-2,822
| -3% | -$285K | 3.64% | 4 |
|
|
2014
Q1 | $10.1M | Sell |
102,856
-1,425
| -1% | -$132K | 3.6% | 4 |
|
|
2013
Q4 | $9.55M | Sell |
104,281
-1,610
| -2% | -$148K | 3.41% | 5 |
|
|
2013
Q3 | $9.18M | Sell |
105,891
-1,659
| -2% | -$149K | 3.64% | 3 |
|
|
2013
Q2 | $9.23M | Buy |
+107,550
| New | +$9.13M | 3.71% | 3 |
|
Other funds holding JNJ
American Research & Management Company's JNJ Position: Q3 2022 in Review
American Research & Management Company reduced its Johnson & Johnson (JNJ) stake by 0.11% in Q3 2022, selling an estimated $13.7K and leaving 72,259 shares worth $11.8M. The position accounts for 3.26% of the portfolio, ranked #5.
American Research & Management Company first reported a position in JNJ in Q2 2013 and has held it in 38 quarters since. The position peaked at $12.8M in Q2 2022. 3,623 funds tracked by Wall St. Rank hold JNJ as of Q3 2022.
- American Research & Management Company held 72,259 shares of Johnson & Johnson worth $11.8M as of Q3 2022.
- American Research & Management Company sold 81 Johnson & Johnson shares in Q3 2022, an estimated $13.7K.
- Johnson & Johnson made up 3.26% of American Research & Management Company's portfolio in Q3 2022, its #5 holding.
- American Research & Management Company first reported a position in Johnson & Johnson in Q2 2013 and has held it in 38 quarters since.
- American Research & Management Company's Johnson & Johnson position peaked at $12.8M in Q2 2022.
- 3,623 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2022.
Based on American Research & Management Company's 13F filing for Q3 2022, filed 7 Oct 2022.